Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
  1. 4 Open-market buy Director bought 20,000 shares at $25.00 ($500,000)
  2. 4 Open-market sale Chief Medical Officer sold 8,000 shares at $28.00 ($224,000)
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale Chief Business Officer sold 16,667 shares at an average $25.07 ($417,860)
  5. 4 Open-market sale Chief Medical Officer sold 6,000 shares at an average $24.32 ($145,919)
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale Chief Development Officer sold 15,000 shares at $22.01 ($330,150)
  8. 4 Open-market sale Chief Medical Officer sold 10,000 shares at $18.67 ($186,700)
  9. 4 Open-market sale 10% owner sold 379,997 shares at $19.50 ($7,409,942)
  10. 4 Open-market sale 10% owner sold 519,385 shares at an average $19.66 ($10,209,721)
  11. 4 Open-market sale 10% owner sold 954,100 shares at $18.52 ($17,669,932)
  12. 4 Open-market sale Chief Medical Officer sold 10,000 shares at $20.03 ($200,300)
  13. 4 Open-market sale Chief Business Officer sold 6,810 shares at $20.13 ($137,069)
  14. 4 Open-market sale Chief Business Officer sold 500 shares at $20.01 ($10,005)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale Chief Business Officer sold 8,956 shares at an average $20.03 ($179,384)
  17. 4 Open-market sale Vice President, Finance sold 1,315 shares at $18.31 ($24,078)
  18. 4 Open-market sale Chief Development Officer sold 7,500 shares at $15.92 ($119,400)
  19. 4 Open-market sale Chief Medical Officer sold 10,000 shares at $15.93 ($159,300)
  20. 4/A Open-market sale Chief Medical Officer sold 2,000 shares at $16.00 ($32,000)

Page 13 of 16 · 301 filings